Search

Search Results

• HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN ADULTS: LOW INCIDENCE OF PRIMARY NEOPLASM AS A TRIGGER IN A CASE SERIES FROM TURKEY

  Ferhat Arslan

  e2018047

  2018-09-01

  https://doi.org/10.4084/mjhid.2018.047

  1663

  PDF: 957

  HTML: 265

  Figure 1: 194

• RECENT ADVANCES IN THE 5Q- SYNDROME

  Andrea Pellagatti, Jacqueline Boultwood

  e2015037

  2015-05-20

  https://doi.org/10.4084/mjhid.2015.037

  2963

  PDF: 1896

  HTML: 3815

  Pellagatti Fig 1: 247

  Pellagatti Fig. 2: 240

• Counting the Cost: How Anticipating Financial Burden Affects Post-Traumatic Stress Symptoms in Patients Newly Diagnosed with Leukemia and Lymphoma

  Fabio Guolo, Paola Del Sette, Francesca Riccardi, Paola Minetto, Andrea Todiere, Filippo Ballerini, Carola Riva, Michele Cea, Roberto Massimo Lemoli, Elena Sarcletti

  2026-02-28

  https://doi.org/10.4084/MJHID.2026.029

  485

  PDF: 441

  HTML: 107

• BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

  Lorenzo Falchi, Jessica M Baron, Carrie Anne Orlikowski, Alessandra Ferrajoli

  e2016011

  2016-02-10

  https://doi.org/10.4084/mjhid.2016.011

  4433

  PDF: 1528

  HTML: 3725

• EBV CHRONIC INFECTIONS

  Eligio Pizzigallo, Delia Racciatti, Valeria Gorgoretti

  e2010022

  2010-08-09

  https://doi.org/10.4084/mjhid.2010.022

  3627

  PDF: 1702

  HTML: 7974

• IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS

  Efterpi Kostareli, Maria Gounari, Andreas Agathangelidis, Kostas Stamatopoulos

  e2012052

  2012-08-09

  https://doi.org/10.4084/mjhid.2012.052

  3193

  PDF: 925

  HTML: 7303

  Kost Fig1: 211

  Kost Fig 2: 198

  Kost Fig3: 204

  Kost Fig 4: 216

  Kost Fig5: 215

  Kost fig 6: 202

• ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA

  Luca Laurenti, Michela Tarnani, Patrizia Chiusolo, Federica Sorà, Simona Sica

  e2010026

  2010-08-31

  https://doi.org/10.4084/mjhid.2010.026

  1454

  PDF: 840

  HTML: 1028

• Zanubrutinib as upfront treatment in de-novo B-cell prolymphocytic leukemia: the case of two elderlies.

  Silvia Giorgi, Giovanna Leonardi, Monica Maccaferri, Elena Sbadili, Carlo Caterina, Giovanni Fera, Ambra Paolini, Leonardo Potenza, Anna Candoni, Mario Luppi, Roberto Marasca

  e2025061

  2025-08-31

  https://doi.org/10.4084/MJHID.2025.061

  1378

  PDF: 615

  Html: 278

• Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES

  Giuseppe Leone, Luigi Maria Larocca, Eligio Pizzigallo

  e2009001

  2009-06-22

  3412

  PDF: 608

  HTML: 725

• HIV AND LYMPHOMA: FROM EPIDEMIOLOGY TO CLINICAL MANAGEMENT Guest Editors: Mario Luppi and Luca Arcaini

  Alessandro Re, Chiara Cattaneo, Giuseppe Rossi

  e2019004

  2019-01-01

  https://doi.org/10.4084/mjhid.2019.004

  3640

  PDF: 2281

  HTML: 464

• THERAPY-RELATED MYELOID NEOPLASMS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND WALDENSTROM MICROGLOBULINEMIA

  Francesca Ricci, Alessandra Tedeschi, Marco Montillo, Enrica Morra

  e2011031

  2011-07-08

  https://doi.org/10.4084/mjhid.2011.031

  2390

  PDF: 979

  HTML: 2417

• MANAGEMENT OF LATENT TUBERCULOSIS INFECTION BASED ON T-SPOT.TB ASSAY IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES

  Emrah Kiliacaslan, Kadir Canoglu

  e2023003

  2022-12-31

  https://doi.org/10.4084/MJHID.2023.003

  1722

  PDF: 1157

  HTML: 527

• Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients

  Alfredo Marzano, Andrea Marengo, Michela di Fonzo, Antonella Ferrari, Bruno Monarca, Gianfranco delle Fave, Massimo Marignani

  e2010035

  2010-12-13

  https://doi.org/10.4084/mjhid.2010.035

  1025

  PDF: 586

  HTML: 2223

  Cover Letter: 215

• Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma

  Valentina Giudice, Luca Pezzullo, Giuseppe Ciancia, Matteo D'Addona, Francesca D'Alto, Marisa Gorrese, Bianca Cuffa, Carmine Selleri

  e2022042

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.042

  952

  PDF: 454

  HTML: 210

• Fournier's Gangrene Complicating Hematologic Malignancies: Literature Review and Treatment Suggestions

  Giovanni D'Arena, Giuseppe Pietrantuono, Emilio Buccino, Giancarlo Pacifico, Pellegrino Musto

  e2013067

  2013-11-04

  https://doi.org/10.4084/mjhid.2013.067

  1666

  PDF: 900

  HTML: 187147

• ELOTUZUMAB FOR THE TREATMENT OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA, WITH SPECIAL REFERENCE TO ITS MODES OF ACTION AND SLAMF7 SIGNALING

  Masafumi Taniwaki, Mihoko Yoshida, Yosuke Matsumoto, Kazuho Shimura, Junya Kuroda, Hiroto Kaneko

  e2018014

  2018-02-15

  https://doi.org/10.4084/mjhid.2018.014

  5394

  PDF: 1996

  HTML: 2078

• AUTOLOGOUS STEM CELL TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA STILL A VALID TREATMENT OPTION, OR IS THE GAME OVER ?

  Fabienne McClanahan, Peter Dreger

  e2012071

  2012-11-06

  https://doi.org/10.4084/mjhid.2012.071

  2560

  PDF: 848

  HTML: 1773

• GASTROINTESTINAL MYELOID SARCOMA A CASE PRESENTATION AND CRITICAL REVIEW OF THE LITERATURE GASTROINTESTINAL MYELOID SARCOMA

  Pouyan Kheirkhah, Ana M. Avila-Rodriguez, Bartlomiej Radzik, Carlos Murga-Zamalloa

  e2021067

  2021-10-29

  https://doi.org/10.4084/MJHID.2021.067

  1662

  PDF: 663

  HTML: 355

• NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria

  Jonathan Braue, Vagishwari Murugesan, Steven Holland, Nishit Patel, Eknath Naik, Jennifer Leiding, Abraham Tareq Yacoub, Carlos N Prieto-Granada, John Norman Greene

  e2015010

  2014-12-27

  https://doi.org/10.4084/mjhid.2015.010

  1912

  PDF: 1147

  HTML: 10753

  Untitled: 213

• Bone marrow involvement in a patient with alpha heavy chain disease:Response to tetracycline treatment

  Zahit Bolaman, Irfan Yavasoglu, Gokhan Sargin, Gurhan Kadikoylu, Firuzan Kacar Doger

  e2012034

  2012-05-07

  https://doi.org/10.4084/mjhid.2012.034

  1272

  PDF: 1044

  HTML: 3419

• APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA

  Tadeusz Robak

  e2010011

  2010-05-07

  https://doi.org/10.4084/mjhid.2010.011

  1706

  PDF: 672

  HTML: 2444

• THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA

  Xenofon Papanikolaou, Bart Barlogie, Saad Usmani

  e2011047

  2011-10-24

  https://doi.org/10.4084/mjhid.2011.047

  2561

  PDF: 821

  HTML: 1746

• ULTRASOUND AS FIRST LINE STEP IN ANAEMIA DIAGNOSTICS

  chiara mozzini, giancarlo pesce, alder casadei, domenico girelli, maurizio soresi

  e2019066

  2019-10-30

  https://doi.org/10.4084/mjhid.2019.066

  1499

  PDF: 922

  HTML: 1961

• ROLE OF COMORBIDITIES IN OPTIMIZING DECISION-MAKING FOR ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

  Mohamed L. Sorror, Rainer F. Storb

  e2010015

  2010-06-08

  https://doi.org/10.4084/mjhid.2010.015

  1050

  PDF: 662

  HTML: 2241

• THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition

  Emiliano Fabiani, Dr. Falconi, Dr. Cristiano, Dr. Hajrullaj, Dr. Falconi, Prof. Leone, Prof. Voso

  e2023064

  2023-10-30

  https://doi.org/10.4084/MJHID.2023.064

  1480

  PDF: 961

  HTML: 253

• PLASMA CELL LEUKEMIA UPDATE ON IMMUNOPHENOTYPE, MOLECULAR CHARACTERISTICS, AND THERAPY. The second part of plasma cell neoplasms with spreading in the blood and tissues Plasma Cell Leukemia

  Giuseppe G.M. Leone, Ugo Testa

  e2025080

  2025-10-31

  https://doi.org/10.4084/MJHID.2025.080

  1693

  PDF: 411

  Html: 234

• Defining invasive fungal infection risk in hematological malignancies: a new tool for clinical practice

  Benedetta Rambaldi, Domenico Russo, Livio Pagano

  e2017012

  2017-01-01

  https://doi.org/10.4084/mjhid.2017.012

  2766

  PDF: 1232

  HTML: 1585

• THE GROWING ROLE OF THE BH3 MIMETIC DRUG VENETOCLAX IN THE THERAPY OF ACUTE MYELOID LEUKEMIA

  Elvira Pelosi, Dr. Germana Castelli, Ugo Testa

  e2022080

  2022-10-29

  https://doi.org/10.4084/MJHID.2022.080

  1593

  PDF: 1225

  HTML: 561

• PROGNOSIS AND THERAPY WHEN ACUTE PROMYELOCYTIC LEUKEMIA AND OTHER “GOOD RISK” ACUTE MYELOID LEUKEMIAS OCCUR AS A THERAPY-RELATED MYELOID NEOPLASM

  Richard A. Larson, Michelle Le Beau

  e2011032

  2011-07-08

  https://doi.org/10.4084/mjhid.2011.032

  2920

  PDF: 971

  HTML: 1884

• A case of fatal hyperammonaemic encephalopathy in a patient with end-stage Multiple Myeloma treated with daratumumab

  Mauro Passucci, Francesca Fazio, Maria Teresa Petrucci

  e2023012

  2023-01-01

  https://doi.org/10.4084/MJHID.2023.012

  1071

  PDF: 988

  HTML: 420

• Orbital Infiltration in a Patient with Waldenström Macroglobulinemia: Need for Multidisciplinary Approach and Comparison with the Literature

  Riccardo Paggi, Francesca Mariotti, Jessica Mencarini, Silvia Bresci, Irene Capolmi, Filippo Bartalesi, Beatrice Borchi, Luca Nassi, Alessandro Maria Vannucchi, Alessandro Bartoloni

  e2023028

  2023-04-28

  https://doi.org/10.4084/MJHID.2023.028

  1096

  PDF: 824

  HTML: 428

• Impact of Sars-CoV-2 prophylaxis with tixagevimab-cilgavimab in high-risk patients with B-cell malignancies: a single-center retrospective study.

  Giovanni Manfredi Assanto ,, Matteo Totaro , Poggiali Rebecca, Delli Paoli Adele, Annechini Giorgia, D’Elia Gianna Maria, Aji Francesco, Petrucci Luigi, Fazio Francesca, Del Giudice Ilaria, Martelli Maurizio, Micozzi Alessandra, Giuseppe Gentile

  e2023061

  2023-10-30

  https://doi.org/10.4084/MJHID.2023.061

  901

  PDF: 476

  HTML: 211

• IMMUNITY TO INFECTIONS AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

  Franco Aversa, Lucia Prezioso, Ilenia Manfra, Federica Galaverna, Angelica Spolzino, Alessandro Monti

  e2016057

  2016-10-25

  https://doi.org/10.4084/mjhid.2016.057

  4493

  PDF: 1169

  HTML: 1444

• Brief tale of a bacteraemia by Rhodococcus equi with concomitant lung mass: what came first, the chicken or the egg?

  Vincenzo Savini, Prassede Salutari, Marco Sborgia

  e2011006

  2011-01-17

  https://doi.org/10.4084/mjhid.2011.006

  1470

  PDF: 854

  HTML: 8673

  Fig 3 Savini: 201

  Fig 2 Savini: 206

  Fig 1 Savini Chest TC: 205

  Author letter to referees: 212

• MOLECULAR CHARACTERIZATION OF EPSTEIN - BARR VIRUS BASED ON EBNA3C PROTEIN AMONG HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS IN JORDAN

  Rabaa Athamneh, Hiba Swaity, Waleed Almomani, Hayyan. Taweil , Assia Benbraiek, Anas Khalifeh

  e2025032

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.032

  917

  PDF: 915

  HTML: 132

• Evaluation of Hepatitis B and C Reactivation in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

  Nathalia Sena de Oliveira Silva, Gislaine Duarte, Samuel de Souza Medina, Guilherme Brasil Duffles Amarante, Carmino Antonio de Souza, Katia Borgia Barbosa Pagnano

  e2026001

  2026-01-01

  https://doi.org/10.4084/MJHID.2026.001

  805

  PDF: 585

  Html: 139

• Cytokine release syndrome after haploidentical transplantation is associated with improved survival without increasing transplant-related mortality

  Daniele Avenoso, Natalia Difrancesco, Enrico Morello, Gabriele Magliano, Mirko Farina, Vera Radici, Simone Bernardi, Alessandro Leoni, Federica Re, Shreyas Hanmantgad, Domenico Russo, Michele Malagola

  e2026059

  2026-06-30

  https://doi.org/10.4084/MJHID.2026.059

  188

  PDF: 162

  HTML: 226

• Guest Editor: Pellegrino Musto AN UPDATE OF THE APPROPRIATE SEQUENCING FOR SALVAGE THERAPIES IN MULTIPLE MYELOMA

  Gregorio Barila', Francesca Rezzonico, Laura Pavan, Alessandro Corso, Renato Zambello

  e2025043

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.043

  1254

  PDF: 1001

  HTML: 285

• CRYOGLOBULIN TEST AND CRYOGLOBULINEMIA HEPATITIS C-VIRUS RELATED

  Umberto Basile

  e2017007

  2017-01-01

  https://doi.org/10.4084/mjhid.2017.007

  4096

  PDF: 1372

  HTML: 2534

• Very late onset Post-Transplantation Lymphoproliferative Disorder (PTLD) after haematopoietic stem cell transplant (HCT) – A Clinical Case

  Sharon Lionel, Liron Barnea Slonim, Guy Hannah, Victoria Potter, Daniele Avenoso

  e2024048

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.048

  1108

  PDF: 1028

  HTML: 164

• COMPARISON OF THREE DISTINCT PROPHYLACTIC AGENTS AGAINST INVASIVE FUNGAL INFECTIONS IN PATIENTS UNDERGOING HAPLO-IDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION AND POST-TRANSPLANT CYCLOPHOSPHAMIDE

  Jean Elcheikh

  e2015048

  2015-08-21

  https://doi.org/10.4084/mjhid.2015.048

  1983

  PDF: 1052

  HTML: 1387

• BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL

  Ugo Testa, Elvira Pelosi, Germana Castelli, Patrizia Chiusolo

  e2024070

  2024-08-31

  https://doi.org/10.4084/MJHID.2024.070

  1742

  PDF: 1139

  HTML: 167

• Guest Edtor: Pellegrino Musto NOVELTIES ON MULTIPLE MYELOMA FROM THE MAIN 2024 HEMATOLOGY CONFERENCES

  Sonia Morè, Laura Corvatta, Valentina Maria Manieri, Erika Morsia, Antonella Poloni, Massimo Offidani

  e2025027

  2025-02-27

  https://doi.org/10.4084/MJHID.2025.027

  1527

  PDF: 1309

  HTML: 402

• PROGNOSTIC IMPACT OF NEUROPILIN-1 EXPRESSION IN EGYPTIAN CHILDREN WITH B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA

  adel abd elhaleim hagag, Nahla A Nosair

  e2015009

  2014-12-28

  https://doi.org/10.4084/mjhid.2015.009

  1689

  PDF: 860

  HTML: 2159

• A case of Pseudo-Richter Transformation following zanubrutinib discontinuation in CLL

  Luca Laurenti, Tommaso Quaranta, Annamaria Tomasso, Luca Stirparo, Pier Luigi Abbate, Arianna Bakacs, Natalia Cappoli, Arianna Di Napoli, Dimitar Efremov, Flaminia Bellisario, Valter Gattei, Carmelo Caldarella, Maria Luisa Calcagni, Francesco Autore, Idanna Innocenti

  e2026070

  2026-09-01

  https://doi.org/10.4084/MJHID.2026.070

  63

  PDF: 39

  Html: 6

• Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF

  Wen Yao, Xinchen Fang, Peng Jiang, Juan Tong, Liangquan Geng, Xiaoyu Zhu, Baolin Tang, Xiang Wan, Kaidi Song, Lei Zhang, Ping Qiang, Guangyu Sun, Yongsheng Han, Huilan Liu, Zimin Sun

  e2022025

  2022-02-27

  https://doi.org/10.4084/MJHID.2022.025

  1856

  PDF: 612

  HTML: 350

• CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL

  Ugo Testa, Prof. Sica, Dr. Pelosi, Dr. Germana Castelli, Prof. Leone

  e2024010

  2024-01-01

  https://doi.org/10.4084/MJHID.2024.010

  4571

  PDF: 3752

  HTML: 373

• ANORECTAL COMPLICATIONS DURING NEUTROPENIC PERIOD IN PATIENTS WITH HEMATOLOGIC DISEASES

  Soner Solmaz

  e2016019

  2016-03-01

  https://doi.org/10.4084/mjhid.2016.019

  3097

  PDF: 1013

  HTML: 1592

• DIFFERENCES IN EX-VIVO CHEMOSENSITIVITY TO ANTHRACYCLINES IN FIRST LINE ACUTE MYELOID LEUKEMIA

  Juan Eduardo Megias-Vericat, David Martínez-Cuadrón, Joaquin Martínez López, Juan Miguel Bergua, Mar Tormo, Josefina Serrano, Ataulfo González, Jaime Pérez de Oteyza, Susana Vives, Belen Vidriales, Pilar Herrera, Juan Antonio Vera, Aurelio López Martínez, Adolfo De la Fuente, María Lourdes Amador, José Ángel Hernández-Rivas, María Ángeles Fernández, Carlos Javier Cerveró, Daniel Morillo, Pilar Hernández Campo, Julián Gorrochategui, Daniel Primo, José Luis Rojas, Margarita Guenova, Joan Ballesteros, Miguel Ángel Sanz, Pau Montesinos

  e2019016

  2019-02-26

  https://doi.org/10.4084/mjhid.2019.016

  2106

  PDF: 1150

  HTML: 324

• THE ROLE OF CORTICOSTEROIDS IN ADULT RESPIRATORY DISTRESS SYNDROME CAUSED BY VIRIDANS GROUP STREPTOCOCCI BACTEREMIA IN NEUTROPENIC PATIENTS

  Abraham Tareq Yacoub, Lysenia Mojica, Lily Jones, Andrea Knab, Sally Alrabaa, John Norman Greene

  e2014055

  2014-09-01

  https://doi.org/10.4084/mjhid.2014.055

  2209

  PDF: 916

  HTML: 1889

  Table: 255